Programmed death ligand 1 (PD-L1) tumor expression is associated with a better prognosis and diabetic disease in triple negative breast cancer patients

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Programmed death ligand 1 (PD-L1) tumor expression is associated with a better prognosis and diabetic disease in triple negative breast cancer patients'. Together they form a unique fingerprint.

Physics & Astronomy

Engineering & Materials Science

Medicine & Life Sciences

Chemical Compounds